Eliquis 2.5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FJRWD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,111
Award facts
- Contract value 100% obligated
- $2,111.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,111.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Eliquis 2.5 mg tablets (60-count packages). The contract was awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, with no set-aside designation applied. DMS Pharmaceutical Group Inc. will perform this delivery order from its Park Ridge, Illinois location, supplying the medication to support Department of Defense healthcare operations. This award does not involve any identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, comprising a 30-month base period with three 30-month option periods. The PPV-G GEN V program is part of the broader $30.3 billion acquisition strategy designed to establish regional prime vendor contractors that supply comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across diverse therapeutic categories positions it as a critical supplier within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FJRWD?
SPE2DB26FJRWD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FJRWD worth?
The government has obligated $2,111 on SPE2DB26FJRWD.
Is contract SPE2DB26FJRWD an order under another contract?
Yes. SPE2DB26FJRWD is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWD competed?
The extent of competition for SPE2DB26FJRWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award